Article
Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer.
International journal of clinical oncology - 1 Apr 2016
Nakagomi Hiroshi, Sakamoto Ikuko, Hirotsu Yosuke, Amemiya Kenji, Mochiduki Hitoshi, Omata Masao
Abstract excerpt
BACKGROUND: PALB2 (Partner and Localizer of BRCA2) was identified as a moderate-risk gene in breast and pancreatic cancers. Recently, it was reported that PALB2 carriers have a high risk of developing breast cancer, with the cumulative risk of 34 % by the age of 70. PATIENTS AND METHODS: Peripheral blood samples from 155 patients at risk for hereditary breast and/or ovarian cancer were tested for BRCA1/2 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
